Ambys Medicines Company

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
Technology:
Stem cell therapy
Industry:
Cell Therapy, Private
Headquarters:
South San Francisco, California, United States
Founded Date:
2018-01-01
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
7
Total Funding:
187000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-12-21
Last Funding Type:
Series A
Register and Claim Ownership